Share Your Feedback

Considering your experience with Sharlife so far, how likely are you to recommend us to a friend or colleague?
Not at all likely Extremely likely
(Optional)
BDX

Becton, Dickinson and Company

BDX Health technology
$53.9B
Market Cap

Shariah Analysis

Failed

Business Cash Liabilities

Based on AAOIFI screening standards, Becton, Dickinson and Company appears to be Failed.

Business Activity
FYE 2025
Non-Permissible Income (<5%) 0.20%
Non-Permissible
$38
Total Income
$21.9K
Revenue Breakdown
Medical
$11.5K
Life Sciences
$5.2K
Interventional
$5.2K
Interest income
Non-Operating
$38
Non-Compliant: $38
Israel involvement

Israel Involvement

Total Funded
$100.0M
Employees in Israel
51-200
Companies Funded
1
Overview

Becton, Dickinson and Company is a global medical technology company engaged principally in the development, manufacture, and sale of medical devices, instrument systems, and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public.The company established its local presence in Israel with the acquisition of Caesarea Medical Electronics, which designs, manufactures and sells IV infusion pumps.

Israeli Portfolio
Caesarea Medical Electronics
Caesarea Medical Electronics

Infusion and Syringe Pump Systems

Raised: $100M 1-10

Market Data

Exchange NYSE NYSE
Currency USD
Country United States
Last Updated 2026-01-13

Disclaimer: Shariah screening is based on the latest available financial data. Market conditions and company activities may change. Always conduct your own due diligence.

Advertisement Banner